Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation by Claudio Ucciferri, Antonio Auricchio, Jacopo Vecchiet, Katia Falasca

Get full text

Cardiac toxicity associated with HCV direct antiviral agents by Claudio Ucciferri, Alessandro Occhionero, Jacopo Vecchiet, Katia Falasca

Get full text

PIDOTIMOD IN PAUCISYMPTOMATIC SARS-CoV2 INFECTED PATIENTS by Claudio Ucciferri, Barone Mirko, Jacopo Vecchiet, Katia Falasca

Get full text

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS by Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet

Get full text

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS by Claudio Ucciferri, Katia Falasca, Paola Mancino, Eligio Pizzigallo, Jacopo Vecchiet

Get full text

Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections by Luca Mezzadri, Nicolò Corti, Elena Ricci, Matteo Faltoni, Giordano Madeddu, Paolo Maggi, Katia Falasca, Alessandra Bandera, Giovanni Cenderello, Michele Bartoletti, Antonio Mastroianni, Letizia Attala, Alessandro Pandolfo, Giuseppe De Socio, Goffredo Angioni, Marco Merli, Marianna Rossi, Paolo Bonfanti

Get full text

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovir... by Nicola Squillace, Elena Ricci, Tiziana Quirino, Andrea Gori, Alessandra Bandera, Laura Carenzi, Giuseppe Vittorio De Socio, Giancarlo Orofino, Canio Martinelli, Giordano Madeddu, Stefano Rusconi, Paolo Maggi, Benedetto Maurizio Celesia, Laura Cordier, Francesca Vichi, Leonardo Calza, Katia Falasca, Antonio Di Biagio, Giovanni Francesco Pellicanò, Paolo Bonfanti, CISAI Study Group

Get full text